Found 73 matching trials
Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
PHASE1This clinical trial will be conducted as a single-center, open-label, Phase...
Location
University of Iowa Hospitals and Clinics
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
PHASE1The purpose of this study is to identify maximum tolerated dose (MTD), that...
Location
Northwestern University
TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer
NAProtocol Synopsis Title A Humanitarian Device Exemption Use Protocol of The...
Location
The Liver Institute at Methodist Dallas Medical Center
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
PHASE3This is a two-arm, open-label, prospective, multi-center, randomized, activ...
Location
Northwestern Medical Faculty Foundation, Div of Hematology/Oncology
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
PHASE1This phase I/II trial tests the safety, side effects and effectiveness of r...
Location
UCLA / Jonsson Comprehensive Cancer Center
TheraSphere With Durvalumab and Tremelimumab for HCC
PHASE2The objective of the ROWAN clinical study is to assess the efficacy of loca...
Status
Active Not Recruiting
Location
University of California San Diego
TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
N/AThe purpose of this protocol is to provide TheraSphere treatment for patien...
Status
Approved For Marketing
Location
Chao Family Comprehensive Cancer Center
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
NAEvaluate the safety and efficacy of Yttrium-90 (90Y) radioembolization for ...
Location
Northwestern University/Northwestern Memorial Hospital
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
PHASE2The purpose of this study is to assess efficacy and tolerance of intra-hepa...
Location
Hôpital Beaujon - Service de Chirurgie
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
N/ATo provide Therasphere treatment for patients diagnosed with unresectable l...
Status
Approved For Marketing
Location
Stanford University School of Medicine